## The challenges facing pharma commercialization teams

#### 01

Regulatory and privacy constraints, especially around PHI, create legal risk and siloed systems across research, marketing, and measurement.

#### 02

Inefficient workflows limit optimization, slow execution, delay time-to-market, and hinder commercialization effectiveness for critical treatments.

#### 03

Integrating AI into existing workflows is complex, but essential to maintaining a strategic advantage in an increasingly competitive marketplace.

## How BranchLab helps pharma

BranchLab reimagines pharma commercialization by accelerating AI adoption through a new class of deep learning models, applied across the entire lifecycle, from insight generation to activation to optimization.

### Privacy

Delivers predictive intelligence, removing legal risk by meeting strict regulatory standards.

### Platform

### Speed

### Integration

## Common use cases for pharma manufacturers

#### High-Performing, Outcome-Based Activation

Activate AI audiences predictive of diagnoses, prescriptions, procedures, and healthcare visits, driving measurable results across all channels.

#### AI-Driven Audience Strategy & Planning

Empower internal teams to design and manage audience strategy for faster, more coordinated decision-making across research, marketing, and measurement.

#### Integrated Measurement of Real-World Impact

Quantify the true effect of commercialization efforts using outcome-based metrics to support continuous optimization and ROI.